Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Ellen M. Martin who wrote (7895)	11/30/1998 7:20:00 PM
From: LarryS	Respond to of 17367

Ellen...wait, don't go. Can't XOMA release a statement about what is expected between now and March on the Meningo Phase III Trial? A lot of us are new to biotech and as you can see from the discussion are confused about what XOMA expects to happen during the next few months. When will the trial actually conclude?? Will it be extended if recommendation comes from DSMB, if so why, and for how long? Will DSMB submit their results and then XOMA will follow with their report at nearly same time? When will both reports be released? Can't the FAQ page be used to update us on what XOMA thinks/knows will actually take place over the next few months?? Pleeeeeasssse. Also, one last question....will the free tickets to Bermuda for next years annual shareholders meeting be included in the prospectus?? :-) By the way, when is the prospectus coming out....thanx.